文献速递关节外科创伤骨科

两阶段全髋关节置换翻修术治疗假体周围感染后治疗失败的患者相关预测因素:系统综述与Meta分析

Patient-Related Predictors of Treatment Failure After Two-Stage Total Hip Arthroplasty Revision for Periprosthetic Joint Infection: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Arthroplasty · 2024-04-26

该系统综述与Meta分析检索1976年12月至2023年4月15日的PubMed、Embase和Scopus数据库,纳入21项比较两阶段翻修全髋关节置换术成功与持续感染患者相关变量的研究。结果显示肥胖、肝硬化、既往因假体周围感染翻修失败为不可改变危险因素,静脉吸毒与吸烟为可改变危险因素,两阶段间再手术与治疗失败风险增加显著相关,而男性、ASA评分、糖尿病和炎性关节病未预测治疗失败。

要点

  • 肥胖、肝硬化、既往因假体周围感染翻修失败为治疗失败的不可改变危险因素。
  • 吸烟和静脉吸毒为可改变危险因素,作者建议尽早转介戒烟戒毒服务。
  • 两阶段间再手术与治疗失败风险增加显著相关。

核心结论

  • 有吸烟史、肥胖、静脉吸毒、既往因假体周围感染翻修失败、两阶段间再手术和肝硬化的患者在两阶段翻修全髋关节置换术治疗假体周围感染后更可能发生治疗失败。
  • 可改变危险因素包括吸烟和静脉吸毒,这些患者应在两阶段翻修全髋关节置换术前尽早转介至戒烟戒毒服务。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Embase和Scopus数据库从建库至1976年12月至2023年4月15日。
  • 纳入比较两阶段翻修全髋关节置换术成功治疗患者与持续感染患者之间患者相关变量的研究。
  • 共筛选10,052项唯一研究,21项研究符合纳入标准进行数据提取。
  • 由两名独立评价者筛选和提取数据,第三名评价者解决分歧。

主要发现

  • 有良好质量证据表明肥胖、肝硬化和既往因假体周围感染翻修失败是两阶段翻修髋关节假体周围感染后治疗失败的不可改变危险因素。
  • 静脉吸毒和吸烟是两阶段翻修髋关节假体周围感染后治疗失败的可改变危险因素。
  • 两阶段翻修间再手术与治疗失败风险增加显著相关。
  • 男性、美国麻醉医师学会评分、糖尿病和炎性关节病等其他假体周围感染危险因素未预测治疗失败。
  • 关于Charlson共病指数的证据有限。

临床怎么用

  • 作者建议有吸烟史、肥胖、静脉吸毒、既往因假体周围感染翻修失败、两阶段间再手术和肝硬化的患者在两阶段翻修全髋关节置换术前尽早转介至戒烟戒毒服务。

局限性

  • 关于Charlson共病指数的证据有限。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Periprosthetic joint infection (PJI) treatment has high failure rates even after 2-stage revision. Risk factors for treatment failure (TF) after staged revision for PJI are not well defined, nor is it well established how they correlate with the risks of developing an index PJI. Identifying modifiable risk factors may allow preoperative optimization, while identifying nonmodifiable risk factors can influence surgical options or advise against further surgery. We performed a systematic review and meta-analysis to better define predictors of TF in 2-stage revision for PJI. METHODS: The PubMed, Embase, and Scopus databases were searched from their inception in December 1976 to April 15, 2023. Studies comparing patient-related variables between patients successfully treated who had 2-staged revision total hip arthroplasty (THA) and patients with persistent infections were included. Studies were screened, and 2 independent reviewers extracted data, while a third resolved discrepancies. Meta-analysis was performed on these data. There were 10,052 unique studies screened, and 21 studies met the inclusion criteria for data extraction. RESULTS: There was good-quality evidence that obesity, liver cirrhosis, and previous failed revisions for PJI are nonmodifiable risk factors, while intravenous drug use (IVDU) and smoking are modifiable risk factors for TF after 2-stage revision for hip PJI. Reoperation between revision stages was also significantly associated with an increased risk of TF. Interestingly, other risk factors for an index PJI including male gender, American Society of Anesthesiology score, diabetes mellitus, and inflammatory arthropathy did not predict TF. Evidence on Charlson Comorbidity Index was limited. CONCLUSIONS: Patients with a smoking history, obesity, IVDU, previous failed revision for PJI, reoperation between stages, and liver cirrhosis are more likely to experience TF after 2-stage revision THA for PJI. Modifiable risk factors include smoking and IVDU and these patients should be referred to services for cessation as early as possible before 2-stage revision THA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Bhanushali A, Tran L, Nairne-Nagy J, et al. Patient-Related Predictors of Treatment Failure After Two-Stage Total Hip Arthroplasty Revision for Periprosthetic Joint Infection: A Systematic Review and Meta-Analysis. J Arthroplasty. 2024. PMID: 38677343. doi:10.1016/j.arth.2024.04.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。